ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma.

Richard P Tobin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.